The primary medications used to treat OCD are a class of antidepressants called SSRIs (selective serotonin reuptake inhibitors). Five medications currently have FDA approval specifically for OCD, and about 60% of patients see their symptoms drop by 40% to 50% or more within 10 to 12 weeks of starting treatment. For people who don’t respond to the first medication, several other options exist, including switching to a different SSRI, adding a second medication, or trying an older antidepressant called clomipramine.
FDA-Approved Medications for OCD
Five medications carry specific FDA approval for OCD. Four are SSRIs, and one is an older tricyclic antidepressant:
- Fluoxetine (Prozac): approved for adults and children 7 and older
- Fluvoxamine (Luvox): approved for adults and children 8 and older
- Sertraline (Zoloft): approved for adults and children 6 and older
- Paroxetine (Paxil): approved for adults only
- Clomipramine (Anafranil): approved for adults and children 10 and older
There is no reliable way to predict which of these will work best for a given person. If one SSRI doesn’t help, another one might. Current clinical guidelines from 2025 recommend SSRIs as the first-line treatment, with clomipramine reserved as a second-line option because of its heavier side effect profile.
Why OCD Requires Higher Doses
OCD typically requires higher doses of SSRIs than depression does. For example, fluoxetine for depression is often effective at 20 mg per day, but OCD treatment can require up to 80 mg. Sertraline may go up to 200 mg, fluvoxamine up to 300 mg, and paroxetine up to 60 mg. In some cases, when a person metabolizes the drug quickly or tolerates it well but isn’t seeing enough improvement after eight or more weeks at the standard maximum, doctors prescribe even higher doses.
These higher doses mean side effects can be more noticeable. Common SSRI side effects include nausea, headache, sleep disruption, sexual difficulties, and weight changes. Most side effects are strongest in the first few weeks and tend to settle as your body adjusts.
How Long Medications Take to Work
One of the most important things to know about OCD medication is the timeline. SSRIs can show a measurable difference compared to placebo within two weeks, but this early improvement is modest. The biggest gains happen in the first six weeks, with roughly 80% of the short-term improvement visible by that point. Symptom improvement follows a pattern where the most dramatic changes come early, then progress slows.
Guidelines recommend staying on a maximally tolerated dose for at least 12 weeks before concluding that a medication isn’t working. That can feel like a long wait, especially if the first few weeks bring side effects without obvious benefit. But stopping too early is one of the most common reasons people miss out on a medication that would have eventually helped.
Clomipramine: The Older Alternative
Clomipramine was actually the first medication shown to be effective for OCD, and it remains a powerful option. It works on serotonin similarly to SSRIs but also affects other brain chemicals, which is why it carries more side effects. These include sedation, dry mouth, constipation, dizziness, and weight gain. It can also affect liver function in some people.
Treatment usually starts at 25 mg per day, increasing gradually over several weeks to a target between 100 and 250 mg per day. Because it causes drowsiness, the larger portion of the dose is often taken at bedtime. Stopping clomipramine abruptly can trigger withdrawal symptoms like dizziness, irritability, headache, and vivid dreams, so any dose changes should be gradual.
Clomipramine is roughly as effective as SSRIs, with about 40% to 60% of patients responding to either class. SSRIs are tried first simply because they’re easier to tolerate.
When the First Medication Doesn’t Work
If you’ve been on an adequate dose of an SSRI for 12 weeks without enough improvement, the next steps generally involve either switching to a different SSRI or adding a second medication on top of the one you’re already taking. Current guidelines favor augmentation (adding a second medication) over switching, particularly for people who had a partial response.
The most studied add-on medications are low-dose atypical antipsychotics, particularly risperidone and aripiprazole, which are considered the first-line augmentation choices. These are used at much lower doses than they would be for conditions like schizophrenia. Guidelines recommend keeping these add-on medications at low-to-medium doses for no longer than three months, discontinuing them if there’s no response.
Cognitive behavioral therapy, specifically a form called exposure and response prevention, also has strong evidence as an add-on for people who partially respond to medication. Combining therapy with an SSRI is one of the most effective overall strategies for OCD.
Newer Augmentation Options
Beyond antipsychotics, several other medications have shown promise as add-ons for people with treatment-resistant OCD. Memantine, a medication originally developed for Alzheimer’s disease, has the best evidence among these newer options. It works on a different brain signaling system (glutamate rather than serotonin) and is generally well tolerated. Two controlled studies have reported significant benefit, and recent guidelines list it as the preferred glutamate-targeting agent for resistant cases.
N-acetylcysteine (NAC), an antioxidant supplement available over the counter, has also shown benefit in controlled studies for OCD that hasn’t responded to standard treatment. Lamotrigine, a mood stabilizer, and certain anti-nausea medications that affect serotonin receptors (ondansetron and granisetron) have emerging evidence supporting their use as well.
Ketamine, which has gained attention for treatment-resistant depression, has produced mixed results in OCD specifically. Some studies suggest it may help with co-occurring depression more than with OCD symptoms themselves.
OCD Medication in Children
For children with mild OCD, therapy alone is the preferred starting point. SSRIs are recommended for children with moderate to severe symptoms, for those who can’t engage effectively in therapy, or when therapy alone isn’t producing enough improvement. Four medications have pediatric FDA approval: sertraline (age 6 and up), fluoxetine (age 7 and up), fluvoxamine (age 8 and up), and clomipramine (age 10 and up). Paroxetine is not approved for children.
Combination treatment with both an SSRI and cognitive behavioral therapy is recommended for moderate to severe OCD in children, or when a single approach hasn’t been enough.
What “Response” Actually Means
It’s worth setting realistic expectations. OCD medication typically reduces symptoms rather than eliminating them entirely. A successful response is generally defined as a 40% to 50% reduction in symptom severity. For many people, that’s the difference between OCD dominating daily life and being manageable enough to function well. Therapy, particularly exposure and response prevention, can close the remaining gap further.
About 40% to 60% of people respond to any given SSRI. That means if the first medication doesn’t work, the odds are still reasonable that a second or third one will. The process of finding the right medication at the right dose can take months, but the majority of people with OCD eventually find a combination that meaningfully reduces their symptoms.